B
KDNY

Bailard’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bailard’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,000
Closed -$100K – 611
2019
Q1 		$100K Buy
+5,000
New +$100K 0.01% 526